Class III · Low risk
Cyanocobalamin Injection
Subpotent Drug: Out of specification for assay.
Is Cyanocobalamin recalled?
Yes — there is an active recall. 19 ongoing FDA recalls mention Cyanocobalamin (75 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Cyanocobalamin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Cyanocobalamin recalls on record
none so far in 2026; 75 on record, newest first
Class III · Low risk
Cyanocobalamin Injection
Subpotent Drug: Out of Specification results for Assay
Class II · Moderate risk
Semaglutide/Cyanocobalamin 5mg/0.2mg/ml
Lack of Assurance of Sterility
Class II · Moderate risk
Semaglutide/Cyanocobalamin 2mg/0.4mg/ml
Lack of Assurance of Sterility
Class II · Moderate risk
FaBB Vitamin B6
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class II · Moderate risk
Cyanocobalamin/Folinic Acid Injection
Lack of Assurance of Sterility
Class II · Moderate risk
Cyanocobalamin Injection
Lack of Assurance of Sterility
Class II · Moderate risk
Methionine 750 mg / Inositol 1
Lack of Assurance of Sterility
Class II · Moderate risk
S-Cyanocobalamin 1
Lack of Assurance of Sterility
Class II · Moderate risk
Methionine 25mg/Inositol 50mg/Choline 50mg/Cyanocobalamin 1mg/ml
Lack of assurance of sterility: Upon review of recent 3rd party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.
Class II · Moderate risk
CYANOCOBALAMIN Injectable-30 mL MDV. Coastal Meds LLC 1759 Medical Park Dr.
Presence of Particulate matter. Recall due to presence of unknown particulate matter.
Class II · Moderate risk
Cyanocobalamin USP
CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.
Class II · Moderate risk
Cyanocobalamin 10ml Mdv 1mg/Ml Inj
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Class II · Moderate risk
Cyanocobalamin 1 mg/mL/ Methionine 25 mg/mL/ Inositol 50 mg/mL/ Choline 50 mg/mL
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
Class II · Moderate risk
Cyanocobalamin Buffered Injectable 3mg/mL
Lack of Assurance of Sterility
Class II · Moderate risk
MIC Combo
Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.
Class II · Moderate risk
Choline chloride 50 mg/mL
Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.
Class II · Moderate risk
Cyanocobalamin Mdv
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Class II · Moderate risk
Chorionic Gonadotropin/Cyanocobalamin
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Class II · Moderate risk
Chorionic Gonadotropin/Cyanocobalamin
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Class II · Moderate risk
Cyanocobalamin 500 mcg/mL Injectable
Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.
Class II · Moderate risk
Lipotropic
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Cyanocobalamin 1
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Cyanocobalamin 1
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Cyanocobalamin 10 mg Pellet
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.